NCT00596427View on ClinicalTrials.gov

Mechanisms of Glucose Lowering Effect of Colesevelam HCl

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions
Diabetes
Interventions
DRUG

Colesevelam HCL

Colesevelam HCL 625 mg: 3 tablets twice per day

DRUG

Placebo

Placebo tablets: 3 tablets twice per day

Trial Locations (3)

33014

Clinical Pharmacology of Miami, Inc, Miami

78229

Diabetes & Glandular Disease Research Associates, San Antonio

94598

Diablo Clinical Research, Inc, Walnut Creek

All Listed Sponsors
lead

Carine Beysen

INDUSTRY

NCT00596427 - Mechanisms of Glucose Lowering Effect of Colesevelam HCl | Biotech Hunter | Biotech Hunter